Related Experiment Video
Updated: Aug 29, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Perceptions and Experiences With Evidence-based Treatments Among People Who Use Opioids
Suzanne Carlberg-Racich1, Darielle Sherrod, Kristin Swope
1From the Master of Public Health Program, DePaul University, Chicago, IL (SC-R); Sinai Urban Health Institute, Chicago, IL (DS); Loyola University School of Medicine, Maywood, IL (KS, DB); Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI (MA); Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI (ES-A).
Objectives:
Even where treatment is available, people who use drugs (PWUD) may not seek help. Few published studies examine beliefs, experiences, and perceptions of evidence-based treatment among PWUD who are not actively engaged in care. This study aimed to explore the experiences of PWUD in considering or accessing treatment and gauge receptiveness to low-threshold treatment models.
Methods:
A purposeful sample of participants actively using opioids and with previous interest in or experience with treatment was recruited from a harm reduction program in Chicago. Semistructured interviews were conducted to explore key phenomena while allowing for unanticipated themes. The instrument included questions about historical drug use, treatment experience, and perceptions of how to improve treatment access and services. Private interviews were audio recorded, transcribed, and double coded by 2 analysts. Queries of coded data were analyzed using issue-focused analysis to identify themes.
Results:
The sample (N = 40) approximated groups at highest risk of fatal overdose in Chicago, with more than 80% between the ages of 45 to 64 years, 65% African American, and 62% male identified. The majority had prior treatment experience, although all resumed use after completing or leaving treatment. The most prevalent barriers to treatment included structural barriers related to social determinants, lack of readiness for abstinence, burdensome intake procedures, and regulatory/programmatic requirements. Most participants expressed interest in low-threshold treatment.
Conclusions:
Existing treatment barriers may be addressed by shifting to lower-threshold intake processes and/or outreach-based delivery of opioid agonist treatment. Engaging PWUD in efforts to create lower-threshold treatment programs is necessary to ensure that needs are met.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
The Placebo Effect
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Receptors: Overview

